Opioid receptor active compounds

Details Opioid receptor active compounds Opioid receptor active compounds

2007-11-13

2007-11-13

Shameem, Golam M. M. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S262200, C514S383000

Reexamination Certificate

active

11337366

ABSTRACT:
The invention provides compounds of formula I:wherein R1to R4and n have any of the meanings defined in the specification and their pharmaceutically acceptable salts. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I, and therapeutic methods for treating pain and treating other conditions which involve, for example, binding opioid receptors using compounds of formula I.

REFERENCES:
patent: 4481360 (1984-11-01), Gall et al.
patent: 4512997 (1985-04-01), Meier et al.
patent: 5108486 (1992-04-01), Kondo et al.
patent: 5310724 (1994-05-01), Kondo et al.
patent: 7045520 (2006-05-01), Welsh et al.
patent: 2269938 (1975-12-01), None
patent: 2000-063363 (2000-02-01), None
patent: WO-99/14204 (1999-03-01), None
patent: WO-00/14066 (2000-03-01), None
Abdelhamid, E. E., et al., “Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice”,Journal of Pharmacol. Exp. Ther., 258(1), (Jul. 1, 1991),299-303.
Bilsky, E. J., et al., “SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist.”,J. Pharmacol. Exp. Ther., 273(1), (Apr. 1995),359-66.
Clemence, Francois , et al., “Synthese et Activite Analgesique Dans La Serie Des Triazoles-1,2,4”,European Journal of Medicinal Chemistry, 20, Editions Scientifique Elsevier, Paris, FR,(1985),257-266.
House, R. V., et al.,Neurosci. Lett., 198, (1995),119.
Lange, Jerzy , et al., “4(H)-1,2,4-Triazole Derivatives with Expected Biological Activity”,Dissertations Pharmaceuticae and Pharmacologicae, 22, (1970),217-221.
Ohsumi, Koji , et al., “Synthesis and Antitumor Activity of Cisrestricted Combretastatins: 5-Membered Heterocyclic Analogues”,Bioorganic&Medicinal Chemistry Letters, 8, Oxford, GB,(1998),3153-3158.
Reid, L. D., et al.,Life Sciences, 52, (1993),PL 67.
Schiller, P. W., et al.,J. Med. Chem., 42, (1999),3520.
Snyder, Solomon H., et al., “Historical Review: Opioid Receptors”,Trends in Pharmacological Sciences, 24, Elsevier, Amsterdam, NL,(Apr. 2003),198-205.
Suzuki, T. , et al., “Preparation of Triazoles as Arginine Vasopressin V1 Receptor Antagonists, and Pharmaceuticals Containing Them”,CAPLUS Database, Abstract Only, Accession No. 2000:136274,(2000),2 p.

Affiliated with

Also associated with

Rating

Opioid receptor active compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Opioid receptor active compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Opioid receptor active compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3881539